https://scholars.lib.ntu.edu.tw/handle/123456789/452206
標題: | Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model | 作者: | Tseng Y.-L. RUEY-LONG HONG Tao M.-H. FU-HSIUNG CHANG |
公開日期: | 1999 | 卷: | 80 | 期: | 5 | 起(迄)頁: | 723-730 | 來源出版物: | International Journal of Cancer | 摘要: | A liposome containing diverse synthetic lipid derivatives of polyethylene glycol (PEG) results in smaller distribution volume and longer circulation time in blood and, thus, may improve drug targeting. The characteristics and therapeutic efficacy of immunoliposomes with similar liposomal formulation have never been studied in lymphoma models. We have developed immunoliposomes conjugated with S5A8 monoclonal antibody, an anti- idiotype antibody to 38C13 murine B-cell lymphoma, and loaded them with doxorubicin using an ammonium sulfate gradient. Purified antibodies were covalently coupled to the termini of PEG on the surface of small unilamellar liposomes. Cell binding and internalization ability of these immunoliposomes were estimated by a fluorescence assay using a pH-sensitive fluorescent dye (HPTS). The in vitro cytotoxicity of doxorubicin encapsulated in immunoliposomes was greater for idiotype-positive 38C13 cells than for the idiotype-negative variant of this cell line. In syngeneic C3H/HeN mice, doxorubicin encapsulated in immunoliposomes exhibited a long circulation time and was more effective at prolonging survival of mice bearing 38C13 tumor than non-targeted liposomal doxorubicin or free doxorubicin plus empty immunoliposomes. Our results demonstrate the superiority of targeted therapy with these immunoliposomes and its potential in lymphoma treatment. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032924292&doi=10.1002%2f%28SICI%291097-0215%2819990301%2980%3a5%3c723%3a%3aAID-IJC16%3e3.0.CO%3b2-L&partnerID=40&md5=05866a25f427a0e041b1e57f994716bb https://scholars.lib.ntu.edu.tw/handle/123456789/452206 |
ISSN: | 00207136 | DOI: | 10.1002/(SICI)1097-0215(19990301)80:5<723 | SDG/關鍵字: | doxorubicin; animal cell; animal model; article; b cell lymphoma; cancer chemotherapy; distribution volume; drug delivery system; drug efficacy; drug stability; drug targeting; female; male; mouse; nonhuman; priority journal; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Doxorubicin; Drug Carriers; Endocytosis; Female; Liposomes; Lymphoma, B-Cell; Male; Metabolic Clearance Rate; Mice; Mice, Inbred C3H; Phosphatidylethanolamines; Polyethylene Glycols |
顯示於: | 生物化學暨分子生物學科研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。